Latest News

Woman receiving eye drops
July 18, 2017

A Switch to Generic Eye Drugs Could Save Medicare Millions Annually

Eye care providers prescribe more brand medications by volume than any other provider group. Efforts to reduce prescription expenditures by eye care providers should focus on increasing the use of generic medications, primarily through therapeutic substitutions. Policy changes enabling Medicare to negotiate prescription drug prices could

Terry Smith, MD, Principal Investigator
May 4, 2017

Study: ‘Breakthrough’ Drug Reduces Graves’ Eye Disease Symptoms

A clinical trial led by the Terry Smith, MD at the University of Michigan Kellogg Eye Center offers hope for those with moderate to severe active thyroid eye disease (TED), also known as Graves’ eye disease. Patients had a significant reduction in symptoms after treatment with teprotumumab, a study drug the Food and Drug Administration

Brendan Hepner and his family at Crisler arena
March 10, 2017

Family’s March Hoops Fundraiser Scores Points for Kellogg Eye Center

March Hoops to BEAT Blindness has a purpose beyond basketball. Organized by Myron Hepner, the event represents another chance to thank the medical teams that saved his infant son’s life after discovering a rare eye cancer and to raise money for vision research. The 2017 beneficiary is Cagri Besirli, MD, PhD. The money will support his study on

Diabetic eye graphic
February 17, 2017

Diabetic Eye Issues a Growing Problem in Youth with the Disease

A large, national study conducted by resident physician Sophia Wang, MD, with Joshua Stein, MD, MS, and Thomas Gardner, MD, MS, suggest youths with T1DM or T2DM exhibit a considerable risk for diabetic retinopathy and should undergo regular screenings by eye-care professionals to ensure timely DR diagnosis and limit progression to vision-

Pages